Paper82837
Cyclosporin A for the treatment of graft-versus-host disease in man.
Powles RL and 5 others. Lancet, 1978. Cited by 240 papers, by iCite.
Cite this record
ConductScience Library. Cyclosporin A for the treatment of graft-versus-host disease in man. Papers, record 82837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/82837
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Fungal Proteins | Major topic |
| Graft vs Host Reaction | Major topic |
| Immunosuppressive Agents | Major topic |
| Peptides, Cyclic | Major topic |
| Postoperative Complications | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Drug Evaluation | |
| Female | |
| Hepatic Encephalopathy | |
| Humans | |
| Injections, Intramuscular | |
| Leukemia, Monocytic, Acute | |
| Leukemia, Myeloid, Acute | |
| Liver Function Tests | |
| Male | |
| Peptides | |
| Transplantation, Isogeneic |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 240 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39231914 | Therapeutic efficacy of rituximab combined with cyclosporin A on B-cell dysregulation in chronic graft-versus-host disease. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39231914 | PubMed |
| 32786098 | Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery. | Photodermatol Photoimmunol Photomed | 2020 | https://conductscience.org/library/papers/32786098 | PubMed |
| 32437331 | Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32437331 | PubMed |
| 23278640 | Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future. | Leuk Lymphoma | 2013 | https://conductscience.org/library/papers/23278640 | PubMed |
| 19857584 | Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19857584 | PubMed |
| 16068182 | Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man. | Nature | 1979 | https://conductscience.org/library/papers/16068182 | PubMed |
| 10833252 | Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. | World J Surg | 2000 | https://conductscience.org/library/papers/10833252 | PubMed |
| 8575558 | The history of cyclosporin A (Sandimmune) revisited: another point of view. | Experientia | 1996 | https://conductscience.org/library/papers/8575558 | PubMed |
| 7459257 | Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A. | Br J Exp Pathol | 1980 | https://conductscience.org/library/papers/7459257 | PubMed |
| 7042484 | Liver disease after bone marrow transplantation. | Gut | 1982 | https://conductscience.org/library/papers/7042484 | PubMed |
| 7041349 | Cyclosporin A hepatotoxicity in 66 renal allograft recipients. | Transplantation | 1981 | https://conductscience.org/library/papers/7041349 | PubMed |
| 7031760 | 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. | Radiology | 1982 | https://conductscience.org/library/papers/7031760 | PubMed |
| 7015660 | Cyclosporin A in clinical organ grafting. First Northern Ireland Kidney Research Fund lecture. | Ulster Med J | 1981 | https://conductscience.org/library/papers/7015660 | PubMed |
| 7000209 | Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980. | Blut | 1980 | https://conductscience.org/library/papers/7000209 | PubMed |
| 6992852 | Effect of cyclosporin A on the survival of corneal grafts in rabbits. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/6992852 | PubMed |
| 6976245 | Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6976245 | PubMed |
| 6972916 | Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A. | Infect Immun | 1981 | https://conductscience.org/library/papers/6972916 | PubMed |
| 6807391 | Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6807391 | PubMed |
| 6797510 | Adult acute leukaemia: prospects for cure. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6797510 | PubMed |
| 6754333 | Cyclosporin A. Clinical pharmacology and therapeutic potential. | Drugs | 1982 | https://conductscience.org/library/papers/6754333 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/82837
GET https://conductscience.org/api/papers/v1/82837/cited_by?page=2